TScan Therapeutics TCRX
NASDAQ TCRX
$0.32 +0.00 (+0.95%)
At close: Oct 1, 2026 · 4:00 PM EDT

TScan Therapeutics (TCRX) Other financing activities (2022 - 2025)

Updated

TScan Therapeutics (TCRX) recorded Other financing activities of $200,000 in FY2025.

Analysis

TScan Therapeutics (TCRX) Other financing activities (2022 - 2025) Analysis & Trends

  • Annual Other financing activities has a three-year compound annual growth rate of -14.9% (FY2022 to FY2025).
  • The FY2025 figure is the highest annual Other financing activities since FY2022.
  • Per Business Quant data, TCRX's Other financing activities was $324,000 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 TScan Therapeutics 40.28 Mn 40.28 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 75,000.00
Mar 31, 2025 125,000.00
Dec 31, 2022 94,000.00
API Access

TScan Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=TCRX&period=max&api_key=YOUR_API_KEY